Clinical Trial

Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

Name: Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury — clinical trial record (NCT05429515)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

In patients with multiple myeloma-related acute kidney injury, compare the renal outcome of chemotherapy combined with HFR-SUPRA to chemotherapy combined with hemodialysis.

Trial Details

NCT Number	NCT05429515
Lead Sponsor	Peking Union Medical College Hospital Collaborators: Bellco Hoxen Medical (Shanghai) Co., Ltd
Conditions	Multiple Myeloma, Acute Kidney Injury, Hemodiafiltration With Ultrafiltrate Regeneration (HFR)
Enrollment	50 participants
Start Date	2022-07-01
Primary Completion	2032-07-01 (estimated)
Study Completion	2032-12-01 (estimated)
Updated on ClinicalTrials.gov	2022-06-23